Skip to main content

Table 3 Factors potentially impacting IFS detection of human brucellosis

From: Detection of Brucellae in peripheral blood mononuclear cells for monitoring therapeutic efficacy of brucellosis infection

  IFS (Nb/%) Total Ρ value
+
Gender* Male 72 (63.2%) 42 (36.8%) 114 0.01
Female 34 (85%) 6 (15%) 40
Status Acute 48 (70.6%) 20 (29.4%) 68 0.676
Chronic 58 (67.4%) 28 (32.6%) 86
Treatment Treated 90 (68.7%) 41 (31.3%) 131 0.934
Untreated 16 (69.9%) 7 (30.4%) 23
Therapy regimen Routine 31 (79.5%) 8 (20.5%) 39 0.088
Addition 44 (63.8%) 25 (36.2%) 69
Mean age 43.4 ± 13.5 43.9 (68.8%) 42.2 (31.2%) 154 0.472
  1. *P value of less than 0.05 was considered significant
  2. #Routine therapy regimen indicated the standard antibiotic treatment; Additional therapy regimen indicated the standard antibiotic treatment additionally receiving immune enhancing drugs
  3. ΔTherapy regimen situation of 23 treated brucellosis patients was missing